Patient-Directed Discharge Among Hospitalized Persons With Opioid Use Disorder in the Fentanyl Era: A Scoping Review
American Journal of Medicine Open · 2026-06 · 15 · 100130
DOI: 10.1016/j.ajmo.2026.100130 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medicine Open, 2026-06. Verfasst von William M Garneau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hospital Medicine, Johns Hopkins Hospital, Baltimore, MD. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Advancing Translational Sciences.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Patient-directed discharge (PDD), also known as discharge against medical advice, is associated with poor outcomes, such as increased hospital readmission and mortality. PDD is 10-20 times more common among persons with opioid use disorder (OUD). This scoping review sought to describe the reported incidence in the fentanyl era and characterize relevant patient level, clinical care level and systems level risk factors that may contribute to this phenomenon.
Methods
A comprehensive assessment of the literature was conducted across 4 electronic databases: PubMed, CINAHL, Cochrane Library and Embase. The search strategy was designed to identify articles reporting PDD incidence and OUD in the era of fentanyl and other highly-potent synthetic opioids.
Results
PDD incidence varies significantly by population; many studies report PDD rate in 10%-20% range and the incidence rate appears to be increasing over time. Younger patients with co-occurring stimulant use and OUD carry the highest rates of PDD. Studies examining the association between medications for OUD (MOUD) and decreased PDD report mixed findings, which likely reflects the impact of variability in medication selection and timing of administration. Consultation with addiction consult service (ACS) was not consistently associated with decreased PDD.
Conclusions
Overall, there is increased rate of PDD in fentanyl era. More work is needed to characterize the relationship between MOUD provision and ACS with incidence of PDD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Hospital Medicine, Johns Hopkins Hospital, Baltimore, MD.
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Medicine, Johns Hopkins Hospital, Baltimore, MD.
- Milken Institute School of Public Health, Washington, DC.
- Department of Medicine, Division of Addiction Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD.
Förderung
- National Center for Advancing Translational Sciences
Zitieren
APA
Garneau, W. M., Kushmeliuk, S., Kee, D. P., Gebo, K. A., & Buresh, M. E. (2026). Patient-Directed Discharge Among Hospitalized Persons With Opioid Use Disorder in the Fentanyl Era: A Scoping Review. American Journal of Medicine Open, 15, 100130. https://doi.org/10.1016/j.ajmo.2026.100130
Vancouver
Garneau WM, Kushmeliuk S, Kee DP, Gebo KA, Buresh ME. Patient-Directed Discharge Among Hospitalized Persons With Opioid Use Disorder in the Fentanyl Era: A Scoping Review. American Journal of Medicine Open. 2026;15:100130. doi:10.1016/j.ajmo.2026.100130
BibTeX
@article{Garneau2026,
author = {Garneau, William M and Kushmeliuk, Severyn and Kee, Dustin P and Gebo, Kelly A and Buresh, Megan E},
title = {Patient-Directed Discharge Among Hospitalized Persons With Opioid Use Disorder in the Fentanyl Era: A Scoping Review},
journal = {American Journal of Medicine Open},
year = {2026},
volume = {15},
pages = {100130},
doi = {10.1016/j.ajmo.2026.100130}
}
EUVIMED